# Crawford & Co: Form 10-Q for the period ended Mar 31, 2021

- Company: [Crawford & Co](/companies/crd-a.md) (CIK 25475)
- Form: 10-Q
- Filed: 2021-05-05
- Accepted by EDGAR: May 5, 2021, 16:35 ET
- Period: 2021-03-31
- Accession: 0001564590-21-024134
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/25475/000156459021024134/crda-10q_20210331.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/25475/000156459021024134/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2021-03-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 3 months, 2021-01-01 to 2021-03-31 | $262.2m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months, 2021-01-01 to 2021-03-31 | $194.2m | us-gaap:CostOfGoodsAndServicesSold |
| Selling, general and administrative | 3 months, 2021-01-01 to 2021-03-31 | $58.7m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Interest expense | 3 months, 2021-01-01 to 2021-03-31 | $1.6m | us-gaap:InterestExpense |
| Income tax | 3 months, 2021-01-01 to 2021-03-31 | $2.5m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2021-01-01 to 2021-03-31 | $6.1m | us-gaap:NetIncomeLoss |
| Operating cash flow | 3 months, 2021-01-01 to 2021-03-31 | $1.6m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 3 months, 2021-01-01 to 2021-03-31 | $618.0k | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 3 months, 2021-01-01 to 2021-03-31 | $3.2m | us-gaap:PaymentsOfDividendsCommonStock |
| Share repurchases | 3 months, 2021-01-01 to 2021-03-31 | $1.2m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | at 2021-03-31 | $42.7m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2021-03-31 | $315.1m | us-gaap:AssetsCurrent |
| Total assets | at 2021-03-31 | $772.7m | us-gaap:Assets |
| Current liabilities | at 2021-03-31 | $235.2m | us-gaap:LiabilitiesCurrent |
| Short-term borrowings | at 2021-03-31 | $3.8m | us-gaap:ShortTermBorrowings |
| Shareholders' equity | at 2021-03-31 | $202.8m | us-gaap:StockholdersEquity |

## Management's discussion and analysis

As filed, 1,770 characters.

The Company's share repurchase authorization, approved on May 9, 2019 by the Company's Board of Directors, provided the Company with the ability to repurchase up to 2,000,000 shares of CRD-A or CRD-B (or a combination of the two) through December 31, 2020 (the "2019 Repurchase Authorization"). The Company’s Board of Directors subsequently amended this authorization to allow for repurchases through December 31, 2021. Under the 2019 Repurchase Authorization, repurchases may be made for cash, in the open market or privately negotiated transactions at such times and for such prices as management deems appropriate, subject to applicable contractual and regulatory restrictions. Since December 31, 2020, the Company has purchased 148,899 shares pursuant to the 2019 Repurchase Authorization. As of March 31, 2021, the Company was authorized to repurchase 493,198 shares under the 2019 Repurchase Authorization.

| Period | Total Number of Shares Purchased | Average Price Paid Per Share | Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs | Maximum Number of Shares That May be Purchased Under the Plans or Programs |
| --- | ---: | ---: | ---: | ---: |
| Balance as of December 31, 2020 |  |  |  | 642,097 |
| January 1, 2021 - January 31, 2021 |  |  |  |  |
| CRD-A | 61,170 | $7.82 | 61,170 |  |
| CRD-B | 38,830 | $7.59 | 38,830 |  |
| Totals of January 31, 2021 |  |  |  | 542,097 |
| February 1, 2021 - February 28, 2021 |  |  |  |  |
| CRD-A | 28,892 | $8.55 | 28,892 |  |
| CRD-B | 20,007 | $8.48 | 20,007 |  |
| Totals of February 28, 2021 |  |  |  | 493,198 |
| March 1, 2021 - March 31, 2021 |  |  |  |  |
| CRD-A | — | $— | — |  |
| CRD-B | — | $— | — |  |
| Totals as of March 31, 2021 | 148,899 |  | 148,899 | 493,198 |

38

## Market risk

As filed, 322 characters.

For a discussion of quantitative and qualitative disclosures about the Company's market risk, see Item 7A, "Quantitative and Qualitative Disclosures About Market Risk," of our Annual Report on Form 10-K for the year ended December 31, 2020. Our exposures to market risk have not changed materially since December 31, 2020.

## Controls and procedures

As filed, 3,190 characters.

### Evaluation of Disclosure Controls and Procedures

We maintain disclosure controls and procedures that are designed to ensure that information required to be disclosed in our Exchange Act reports is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission's rules and forms, and that such information is accumulated and communicated to management, including the Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure. Management necessarily applies its judgment in assessing the costs and benefits of such controls and procedures, which, by their nature, can provide only reasonable assurance regarding management's control objectives. The Company's management, including the Chief Executive Officer and the Chief Financial Officer, does not expect that our disclosure controls and procedures can prevent all possible errors or fraud. A control system, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that misstatements due to error or fraud will not occur or that all control issues and instances of fraud, if any, within the Company have been detected. There are inherent limitations in all control systems, including the realities that judgments in decision-making can be faulty, and that breakdowns can occur because of simple errors or mistakes. Additionally, controls can be circumvented by the individual acts of one or more persons. The design of any system of controls is based in part upon certain assumptions about the likelihood of future events, and, while our disclosure controls and procedures are designed to be effective under circumstances where they should reasonably be expected to operate effectively, there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions. Because of the inherent limitations in any control system, misstatements due to possible errors or fraud may occur and not be detected.

As of the end of the period covered by this report, we performed an evaluation, under the supervision and with the participation of management, including the Chief Executive Officer and Chief Financial Officer, of the effectiveness of the design and operation of our disclosure controls and procedures pursuant to Exchange Act Rules 13a-15(b) and 15d-15(b). Based upon the foregoing, the Chief Executive Officer along with the Chief Financial Officer concluded that, as of the end of the period covered by this report, our disclosure controls and procedures were effective at providing reasonable assurance that all information relating to the Company (including its consolidated subsidiaries) required to be disclosed in our Exchange Act reports is recorded, processed, summarized, and reported in a timely manner.

### Changes in Internal Control over Financial Reporting

There were no changes in our internal control over financial reporting that occurred during the period covered by this report that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

## Risk factors

As filed, 593 characters.

In addition to the other information set forth in this report, the factors discussed in Part I, "Item 1A. Risk Factors" in our Annual Report on Form 10-K for the year ended December 31, 2020 could materially affect our business, financial condition, or results of operations. The risks described in this report and in our Annual Report on Form 10-K are not the only risks facing our Company. Additional risks and uncertainties not currently known to us or that we currently deem to be immaterial also may materially adversely affect our business, financial condition, or results of operations.

Filed May 5, 2021.
Source: SEC EDGAR, the filing index for accession 0001564590-21-024134. Last ingested by Listed: Nov 12, 2026, 23:38 ET. No prices; not investment advice.
